快速微生物檢測市場規模、佔有率和成長分析（按產品、應用、方法和地區分類）—2026-2033年產業預測

全球快速微生物檢測市場規模預計在 2024 年達到 59.4 億美元，從 2025 年的 64.6 億美元成長到 2033 年的 126.9 億美元，在預測期（2026-2033 年）內複合年成長率為 8.8%。

全球快速微生物檢測市場的需求主要源自於對微生物進行近即時分析的迫切需要，而這種分析需要避免傳統實驗室方法耗時的流程。都市化的加速加劇了水污染，並導致包括沙​​門氏菌等病原體引起的嚴重感染疾病在內的多種疾病的傳播。目前的檢測方法在速度和準確性方面往往存在不足，凸顯了對快速微生物檢測解決方案的迫切需求。此外，包裝食品消費量的不斷成長也進一步刺激了這一需求，因為污染事件可能導致嚴重的公共衛生風險和代價高昂的產品召回。快速檢測方法能夠實現及時的微生物監測，為各行業的品管提供關鍵訊息，並確保食品生產和水資源管理的安全性和合規性。

推動全球快速微生物檢測市場發展的因素

感染疾病（尤其是醫院感染）發生率的上升以及抗生素抗藥性問題的日益嚴峻，正顯著推動全球對快速微生物檢測的需求。政府和私營部門都在增加對醫療保健的投資，尤其是在新興市場，這使得建立先進的診斷能力以有效應對感染疾病疫情成為當務之急。此外，人們越來越認知到早期診斷的準確性對於改善患者預後至關重要。這些因素共同推動著創新微生物解決方案在全球範圍內的廣泛應用。

全球快速微生物檢測市場限制因素

全球快速微生物檢測市場面臨許多限制因素，其中最主要的是部署和維護先進檢測設備的高成本。許多實驗室和醫療機構，尤其是在低收入和發展中地區，都難以承擔這些先進系統帶來的經濟負擔，包括初始投資和持續的基礎設施維護成本。因此，預算有限的小規模實驗室和醫院往往難以從傳統診斷方法過渡到更有效率的快速微生物檢測解決方案。這種經濟限制因素嚴重阻礙了快速微生物檢測市場的成長和普及。

全球快速微生物檢測市場趨勢

全球快速微生物檢測市場正經歷一場由人工智慧 (AI) 和巨量資料分析融合驅動的重大變革，預示著診斷效率的新紀元。人工智慧解決方案顯著提升了快速處理和分析大量資料集的能力，從而在微生物檢測中提供更快、更準確的結果。這項技術進步賦予了醫療專業人員預測模型，使其能夠預見感染疾病爆發並制定有效的預防措施。因此，這項創新不僅改善了患者照護，還最佳化了臨床資源配置，使快速微生物檢測成為現代醫學進步的前沿技術。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境
• 專利分析

全球快速微生物檢測市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 裝置
• 試劑和試劑盒
• 消耗品

全球快速微生物檢測市場規模（按方法和複合年成長率分類）（2026-2033 年）

• 基於生長的快速微生物檢測
• 快速細胞微生物檢測
• 基於核酸的快速微生物檢測
• 基於活性的快速微生物檢測

全球快速微生物檢測市場規模（按應用領域及複合年成長率分類）（2026-2033 年）

• 臨床疾病診斷
• 食品和飲料檢查
• 藥物和生物技術檢測
• 環境檢查
• 研究用途

全球快速微生物檢測市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院和診斷檢查室
• 製藥和生物技術公司
• 受託研究機構（CRO）
• 學術研究機構
• 食品和飲料公司

全球快速微生物檢測市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Becton, Dickinson and Company（USA）
• bioMerieux SA（France）
• Danaher Corporation（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Sartorius AG（Germany）
• Bruker Corporation（USA）
• QuidelOrtho Corporation（USA）
• Charles River Laboratories（USA）
• Neogen Corporation（USA）
• Don Whitley Scientific Limited（UK）
• Rapid Micro Biosystems, Inc.（USA）
• Gradientech（Sweden）
• rqmicro AG（Switzerland）
• Colifast AS（Norway）
• Serosep Limited（Ireland）
• Solus PerkinElmer（USA）
• BTNX Inc.（Canada）
• R-Biopharm AG（Germany）

結論與建議

Global Rapid Microbiology Testing Market size was valued at USD 5.94 Billion in 2024 and is poised to grow from USD 6.46 Billion in 2025 to USD 12.69 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

The global market for rapid microbiology testing is driven by the urgent need for near real-time analysis of microorganisms without the lengthy processes associated with traditional lab methods. Increasing urbanization has exacerbated water pollution, contributing to widespread diseases, including significant infections caused by pathogens like Salmonella. Current detection methods often fall short in speed and accuracy, highlighting the critical demand for rapid microbiology solutions. Furthermore, the rising consumption of packaged foods amplifies this need, as incidents of contamination can lead to severe public health risks and costly recalls. Rapid testing methods enable timely microbial monitoring, providing essential insights for maintaining quality control across various sectors, ensuring safety and compliance in food production and water management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Microbiology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Microbiology Testing Market Segments Analysis

Global Rapid Microbiology Testing Market is segmented by Product, Method, Application, End User and region. Based on Product, the market is segmented into Instruments, Reagents and Kits and Consumables. Based on Method, the market is segmented into Growth-Based Rapid Microbiology Testing, Cellular Component-Based Rapid Microbiology Testing, Nucleic Acid-Based Rapid Microbiology Testing and Viability-Based Rapid Microbiology Testing. Based on Application, the market is segmented into Clinical Disease Diagnostics, Food and Beverage Testing, Pharmaceutical and Biotechnology Testing, Environmental Testing and Research Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes and Food and Beverage Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Microbiology Testing Market

The escalating incidence of infectious diseases, particularly hospital-acquired infections and the growing challenges of antibiotic resistance, has spurred a significant demand for rapid microbiology testing worldwide. Enhanced investments in healthcare, particularly in emerging markets, are being driven by both governmental and private sectors, which are prioritizing the establishment of advanced diagnostic capabilities to effectively address outbreaks. Furthermore, there is a heightened awareness of the importance of early diagnostic precision, which is crucial for improving patient outcomes. This combination of factors is fostering the widespread adoption of innovative microbiological solutions across the globe.

Restraints in the Global Rapid Microbiology Testing Market

The Global Rapid Microbiology Testing market faces significant constraints due to the high costs associated with acquiring and maintaining advanced testing equipment. Many laboratories and healthcare facilities, particularly in low-income and underdeveloped areas, struggle with the financial burden of these sophisticated systems, which includes both initial investment and ongoing infrastructure maintenance expenses. As a result, smaller laboratories and hospitals, constrained by their budgets, often find it challenging to transition from traditional diagnostic methods to more efficient rapid microbiological solutions. This financial limitation significantly hampers the growth and adoption of rapid microbiological testing across the market.

Market Trends of the Global Rapid Microbiology Testing Market

The Global Rapid Microbiology Testing market is experiencing a significant transformation driven by the integration of artificial intelligence (AI) and big data analytics, heralding a new era in diagnostic efficacy. AI-powered solutions are enhancing the ability to process and analyze vast datasets swiftly, yielding quicker and more precise outcomes for microbial assessments. This technological advancement also empowers healthcare professionals with predictive modeling, enabling them to foresee infection outbreaks and tailor preventive measures effectively. Consequently, this innovation is not only improving patient care but also optimizing resource allocation in clinical settings, positioning rapid microbiological testing at the forefront of modern healthcare advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Rapid Microbiology Testing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents and Kits
• Consumables

Global Rapid Microbiology Testing Market Size by Method & CAGR (2026-2033)

• Market Overview
• Growth-Based Rapid Microbiology Testing
• Cellular Component-Based Rapid Microbiology Testing
• Nucleic Acid-Based Rapid Microbiology Testing
• Viability-Based Rapid Microbiology Testing

Global Rapid Microbiology Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Disease Diagnostics
• Food and Beverage Testing
• Pharmaceutical and Biotechnology Testing
• Environmental Testing
• Research Applications

Global Rapid Microbiology Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes
• Food and Beverage Companies

Global Rapid Microbiology Testing Market Size & CAGR (2026-2033)

• North America (Product, Method, Application, End User)
  • US
  • Canada
• Europe (Product, Method, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Don Whitley Scientific Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Micro Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gradientech (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• rqmicro AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colifast AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serosep Limited (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solus PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTNX Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations